The following table summarizes the changes in the Company’s investments in Alzamend common stock during the six months ended June 30, 2022: (Details) - USD ($)		6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021
Restructuring Cost and Reserve [Line Items]
Stock Issued During Period, Value, Other			$ 450,000
Common Stock [Member]
Restructuring Cost and Reserve [Line Items]
Stock Issued During Period, Value, Other
Alzamend [Member] | Common Stock [Member]
Restructuring Cost and Reserve [Line Items]
Begining balance (in shares)		6,947,000
Begining balance (in dollars per shares)		$ 1.90
Begining balance		$ 13,230,000
Securities purchase agreement (in shares)	[1]	2,667,000
Securities purchase agreement (in dollars per shares)	[1]	$ 1.50
Securities purchase agreement	[1]	$ 4,000,000
Open market purchases after initial public offering (in shares)		618,000
Open market purchases after initial public offering (in dollars per shares)		$ 1.07
Open market purchases after initial public offering		$ 663,000
Stock Issued During Period, Value, Other		$ (9,048,000)
Ending balance (in shrares)		10,232,000
Ending balance (in dollars per shares)		$ 0.86
Ending balance		$ 8,845,000

[1] Pursuant to the March 9, 2021 securities purchase agreement, in aggregate, Alzamend agreed to sell up to 6,666,667 shares of its common stock to DP Lending for $10.0 million, or $1.50 per share, and issue to DP Lending warrants to acquire 3,333,334 shares of Alzamend common stock with an exercise price of $3.00 per share. As of December 31, 2021, DP Lending funded $6.0 million, including the conversion of notes and advances of $0.8 million, and the remaining $4.0 million was funded upon Alzamend achieving certain milestones during the three months ended June 30, 2022.